PerpEquities

argenx SE (ARGX) balance sheet

NASDAQ · Healthcare · Biotechnology · 1,863 employees · CEO Karen Massey

Price
$892.87 -0.55%
Market cap
$56.1B
Enterprise value
$53.2B
Last report
Q4 '26 filed 2026-09-30
Next report
2027-02-25 EPS est. $7.70

At the end of Q2 '26 argenx SE (ARGX) held $5.18B in cash and short-term investments against $47M of debt incl. leases. Total assets $10B, total liabilities $1.62B, shareholders' equity $8.42B.

Balance sheet

Balance sheetTrendQ4 '20Q2 '21Q4 '21Q2 '22Q4 '22Q2 '23Q4 '23Q2 '24Q4 '24Q2 '25Q4 '25Q2 '26
Assets
Cash & equivalents$1.22B$1.58B$1.33B$1.37B$801M$1.11B$2.05B$1.44B$1.5B$2.09B$3.49B$3.58B
Short-term investments$780M$1.15B$1B$1.23B$1.39B$886M$1.13B$1.66B$1.88B$1.84B$949M$1.6B
Receivables$7.44M$12.1M$38.2M$114M$277M$355M$499M$656M$909M$1.2B$1.66B$1.94B
Inventory$25.2M$59.2M$109M$136M$228M$201M$311M$326M$407M$341M$474M$371M
Other current assets$5.86M$1K$0$1.47M-$1K$0$0$0$0$1K$0$0
Current assets$2.06B$2.86B$2.54B$2.93B$2.77B$2.69B$4.12B$4.26B$4.88B$5.83B$6.9B$8.07B
Property, plant & equipment (net)$11.6M$11.4M$15.8M$14.2M$16.2M$13.4M$22.7M$36.9M$43.5M$45.8M$48.2M$52M
Long-term investments$6.31M$118M$53.2M$41.4M$40.5M$49.9M$47.2M$38.6M$49.7M$10.7M$89.6M$69M
Goodwill$0$0$0$0$0$0$0$9.43M$0$0$0$0
Intangible assets$167M$175M$172M$171M$175M$190M$125M$132M$181M$219M$272M$266M
Deferred tax assets$15M$16.3M$32.2M$54.3M$79.2M$139M$97.2M$175M$924M$900M$1.3B$1.43B
Other non-current assets$22.1M$27.5M$34.4M$38.7M$49.2M$109M$126M$141M$120M$171M$77.8M$148M
Non-current assets$222M$348M$307M$320M$360M$502M$419M$533M$1.32B$1.35B$1.78B$1.96B
Total assets$2.28B$3.21B$2.85B$3.25B$3.13B$3.19B$4.54B$4.8B$6.2B$7.18B$8.68B$10B
Liabilities
Accounts payable$275M$239M$293M$167M$189M$195M$246M$281M$342M$532M$1.27B$718M
Accrued expenses$0$0$0$75.3M$84.3M$70.2M$95.1M$107M$151M$128M$0$197M
Short-term debt$3.48M$3.45M$3.51M$3.49M$3.42M$3.2M$4.65M$5.85M$6.53M$7.58M$10.8M$11M
Taxes payable$3.5M$1.15M$4.32M$3.42M$3.18M$4.61M$4.33M$13.9M$13.4M$18.2M$0$49M
Deferred revenue$46.3M$0$0$8.72M$0$0$0$0$0$0$0$0
Other current liabilities$0$0$0$6.49M$22.6M$44.5M$73.4M$92.5M$157M$356M$0$600M
Current liabilities$328M$244M$301M$265M$302M$318M$423M$500M$670M$1.04B$1.32B$1.58B
Long-term debt$0$0$0$0$0$0$0$0$0$0$36.3M$0
Lease obligations (non-current)$6.18M$4.43M$7.96M$6.21M$9.01M$8.04M$15.4M$28.1M$32.5M$35.6M$36.3M$36M
Deferred revenue (non-current)$269M$0$0$0$0$0$0$0$0$0$0$0
Deferred tax liabilities$1.49M$12.4M$6.44M$7.66M$8.41M$8.89M$5.16M$4.99M$0$0$0$0
Other non-current liabilities$156K$227K$417K$546K$870K$1.01M$1.45M$1.58M$1.8M$2.37M-$33.2M$4M
Non-current liabilities$277M$17M$14.8M$14.4M$18.3M$17.9M$22M$34.7M$34.3M$37.9M$39.4M$40M
Total liabilities$605M$261M$316M$279M$321M$336M$445M$534M$704M$1.08B$1.36B$1.62B
Equity
Common stock & paid-in capital$5.74M$6.2M$6.23M$6.6M$6.64M$6.7M$7.06M$7.12M$6.98M$7.26M$7.35M$7M
Retained earnings-$992M-$929M-$1.4B-$1.84B-$2.11B-$2.23B-$2.4B-$2.44B-$1.57B-$1.16B-$280M$558M
Accumulated other comprehensive income$321M$432M$465M$527M$71.7M$710M$72.1M$945M$66.7M$78.2M$73.6M$1.54B
Shareholders' equity$1.67B$2.95B$2.53B$2.97B$2.81B$2.86B$4.1B$4.26B$5.5B$6.1B$7.32B$8.42B
Debt
Total debt (incl. leases)$9.66M$7.88M$11.5M$9.7M$12.4M$11.2M$20M$34M$39.1M$43.2M$83.5M$47M
Net debt (debt - cash)-$1.21B-$1.57B-$1.32B-$1.36B-$788M-$1.1B-$2.03B-$1.4B-$1.46B-$2.04B-$3.41B-$3.54B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates: Financial Modeling Prep.

Data as of 2026-11-02